Biotechnology
The Biotechnology industry has a total of 620 stocks, with a combined market cap of $935.4 billion and total revenue of $101.41 billion.
Market Cap
935.4B
Revenue
101.41B
Profits
-42.52B
PE Ratio
n/a
Profit Margin
-41.93%
Dividend Yield
0.04%
619 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 98.90B | 1.01% | 1,841,275 | 11.42B |
| 2 | ALNY | Alnylam Pharmaceuticals, Inc. | 58.51B | -0.71% | 808,673 | 2.46B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 58.47B | 1.51% | 839,747 | 14.21B |
| 4 | ARGX | argenx SE | 43.88B | 0.13% | 198,373 | 3.12B |
| 5 | ONC | BeOne Medicines AG | 35.90B | -0.81% | 198,178 | 4.56B |
| 6 | INSM | Insmed Incorporated | 28.96B | 1.06% | 1,391,779 | 398.11M |
| 7 | BNTX | BioNTech SE | 23.58B | - | 570,485 | 3.38B |
| 8 | RPRX | Royalty Pharma plc | 20.43B | 0.40% | 4,762,365 | 2.31B |
| 9 | GMAB | Genmab A/S | 17.75B | 0.80% | 1,029,783 | 3.65B |
| 10 | INCY | Incyte Corporation | 16.15B | 1.27% | 1,237,141 | 4.58B |
| 11 | SMMT | Summit Therapeutics Inc. | 15.56B | 3.41% | 3,282,553 | - |
| 12 | ASND | Ascendis Pharma A/S | 11.63B | 1.19% | 273,288 | 576.33M |
| 13 | EXEL | Exelixis, Inc. | 10.51B | 0.90% | 1,641,654 | 2.23B |
| 14 | ROIV | Roivant Sciences Ltd. | 10.36B | 1.40% | 5,835,958 | 23.23M |
| 15 | BMRN | BioMarin Pharmaceutical Inc. | 10.34B | 2.34% | 1,845,566 | 3.06B |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 10.22B | 1.78% | 1,523,660 | 944.05M |
| 17 | BBIO | BridgeBio Pharma, Inc. | 9.57B | 2.14% | 1,506,155 | 235.81M |
| 18 | MRNA | Moderna, Inc. | 9.53B | -0.49% | 10,242,540 | 3.08B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.46B | 0.29% | 379,367 | 515.55M |
| 20 | VRNA | Verona Pharma plc | 9.20B | - | 1,268,177 | 221.67M |
| 21 | CORT | Corcept Therapeutics Incorporated | 8.84B | 1.38% | 484,001 | 716.08M |
| 22 | HALO | Halozyme Therapeutics, Inc. | 8.63B | -0.30% | 2,223,943 | 1.18B |
| 23 | RVMD | Revolution Medicines, Inc. | 8.21B | 3.32% | 1,936,357 | - |
| 24 | CAI | Caris Life Sciences, Inc. | 8.21B | -1.82% | 980,201 | 533.85M |
| 25 | TECH | Bio-Techne Corporation | 8.07B | 2.69% | 1,695,491 | 1.22B |
| 26 | JAZZ | Jazz Pharmaceuticals plc | 7.70B | -0.63% | 611,662 | 4.09B |
| 27 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.59B | 0.02% | 558,302 | 156.29M |
| 28 | ABVX | ABIVAX Société Anonyme | 6.21B | 1.02% | 767,715 | 7.07M |
| 29 | RNA | Avidity Biosciences, Inc. | 6.17B | 5.17% | 3,169,918 | 10.73M |
| 30 | LEGN | Legend Biotech Corporation | 6.16B | 1.68% | 793,652 | 796.84M |
| 31 | CYTK | Cytokinetics, Incorporated | 6.03B | 5.37% | 2,117,796 | 85.74M |
| 32 | NUVL | Nuvalent, Inc. | 5.87B | 4.99% | 379,148 | - |
| 33 | AXSM | Axsome Therapeutics, Inc. | 5.83B | 0.65% | 347,065 | 495.03M |
| 34 | CRSP | CRISPR Therapeutics AG | 5.61B | 2.24% | 1,972,275 | 38.05M |
| 35 | MTSR | Metsera, Inc. | 5.50B | -0.50% | 2,591,792 | - |
| 36 | MRUS | Merus N.V. | 5.21B | 1.16% | 603,783 | 56.23M |
| 37 | TGTX | TG Therapeutics, Inc. | 5.18B | 2.48% | 1,522,778 | 454.07M |
| 38 | KRYS | Krystal Biotech, Inc. | 4.86B | 4.14% | 210,612 | 359.21M |
| 39 | PTCT | PTC Therapeutics, Inc. | 4.69B | 1.99% | 888,221 | 1.76B |
| 40 | ARWR | Arrowhead Pharmaceuticals, Inc. | 4.53B | 3.60% | 1,879,655 | 572.98M |
| 41 | ACLX | Arcellx, Inc. | 4.42B | 1.63% | 479,635 | 56.98M |
| 42 | PCVX | Vaxcyte, Inc. | 4.41B | 5.72% | 2,021,278 | - |
| 43 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.32B | 27.92% | 10,234,906 | 1.39M |
| 44 | PTGX | Protagonist Therapeutics, Inc. | 4.19B | 4.20% | 1,434,997 | 209.18M |
| 45 | KYMR | Kymera Therapeutics, Inc. | 4.02B | 4.67% | 1,260,825 | 44.71M |
| 46 | QURE | uniQure N.V. | 4.01B | 3.15% | 11,296,669 | 14.34M |
| 47 | MLTX | MoonLake Immunotherapeutics | 3.94B | 9.95% | 1,149,831 | - |
| 48 | AKRO | Akero Therapeutics, Inc. | 3.82B | 3.29% | 745,035 | - |
| 49 | ADMA | ADMA Biologics, Inc. | 3.73B | 1.89% | 2,550,131 | 474.17M |
| 50 | SRRK | Scholar Rock Holding Corporation | 3.72B | 12.35% | 4,409,220 | - |
| 51 | MIRM | Mirum Pharmaceuticals, Inc. | 3.66B | -1.10% | 654,528 | 429.16M |
| 52 | ACAD | ACADIA Pharmaceuticals Inc. | 3.55B | -0.75% | 2,950,301 | 1.02B |
| 53 | ZLAB | Zai Lab Limited | 3.52B | -0.03% | 365,116 | 427.80M |
| 54 | SLNO | Soleno Therapeutics, Inc. | 3.45B | 3.57% | 1,569,058 | 32.66M |
| 55 | AAPG | Ascentage Pharma Group International | 3.43B | -1.40% | 2,081 | 54.52M |
| 56 | TLX | Telix Pharmaceuticals Limited | 3.29B | -1.78% | 227,673 | 664.23M |
| 57 | NAMS | NewAmsterdam Pharma Company N.V. | 3.21B | 8.41% | 755,946 | 64.01M |
| 58 | CNTA | Centessa Pharmaceuticals plc | 3.12B | 1.09% | 986,649 | 15.00M |
| 59 | MLYS | Mineralys Therapeutics, Inc. | 3.10B | 3.84% | 1,641,941 | - |
| 60 | XENE | Xenon Pharmaceuticals Inc. | 2.93B | 4.00% | 694,136 | 7.50M |
| 61 | VKTX | Viking Therapeutics, Inc. | 2.88B | 1.91% | 3,711,090 | - |
| 62 | CGON | CG Oncology, Inc. | 2.86B | 2.91% | 629,655 | 551.00K |
| 63 | IMVT | Immunovant, Inc. | 2.83B | 3.57% | 2,211,918 | - |
| 64 | APLS | Apellis Pharmaceuticals, Inc. | 2.83B | 0.77% | 2,775,258 | 754.65M |
| 65 | RARE | Ultragenyx Pharmaceutical Inc. | 2.80B | 4.53% | 2,660,307 | 610.16M |
| 66 | FOLD | Amicus Therapeutics, Inc. | 2.54B | -0.96% | 4,793,203 | 571.16M |
| 67 | IBRX | ImmunityBio, Inc. | 2.40B | 3.25% | 5,851,541 | 56.60M |
| 68 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.39B | 2.04% | 1,265,158 | 558.50M |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 2.38B | 1.62% | 396,445 | 295.52M |
| 70 | IDYA | IDEAYA Biosciences, Inc. | 2.35B | 4.44% | 1,863,908 | 7.00M |
| 71 | BLTE | Belite Bio, Inc | 2.30B | -0.04% | 49,317 | - |
| 72 | CDTX | Cidara Therapeutics, Inc. | 2.29B | 6.77% | 2,135,204 | 302.00K |
| 73 | IRON | Disc Medicine, Inc. | 2.28B | 4.88% | 356,444 | - |
| 74 | AGIO | Agios Pharmaceuticals, Inc. | 2.26B | 6.34% | 824,860 | 40.88M |
| 75 | BEAM | Beam Therapeutics Inc. | 2.26B | -0.52% | 2,001,432 | 60.27M |
| 76 | TVTX | Travere Therapeutics, Inc. | 2.26B | 2.80% | 1,277,408 | 333.87M |
| 77 | APGE | Apogee Therapeutics, Inc. | 2.24B | 1.84% | 655,017 | - |
| 78 | ETNB | 89bio, Inc. | 2.18B | - | 6,177,757 | - |
| 79 | GLPG | Galapagos NV | 2.18B | 3.43% | 179,106 | 323.67M |
| 80 | OCUL | Ocular Therapeutix, Inc. | 2.18B | 2.37% | 2,003,991 | 56.66M |
| 81 | CELC | Celcuity Inc. | 2.15B | -2.58% | 982,343 | - |
| 82 | ARQT | Arcutis Biotherapeutics, Inc. | 2.11B | 5.02% | 1,454,749 | 263.47M |
| 83 | RXRX | Recursion Pharmaceuticals, Inc. | 2.06B | 1.94% | 39,410,313 | 64.60M |
| 84 | DNLI | Denali Therapeutics Inc. | 2.04B | 3.87% | 2,351,929 | - |
| 85 | ADPT | Adaptive Biotechnologies Corporation | 2.01B | 0.69% | 1,394,767 | 205.22M |
| 86 | MESO | Mesoblast Limited | 2.01B | -2.76% | 124,227 | 17.20M |
| 87 | COGT | Cogent Biosciences, Inc. | 1.98B | 6.55% | 2,973,853 | - |
| 88 | LQDA | Liquidia Corporation | 1.88B | -2.90% | 3,733,700 | 19.32M |
| 89 | DYN | Dyne Therapeutics, Inc. | 1.87B | 4.53% | 1,414,947 | - |
| 90 | VERA | Vera Therapeutics, Inc. | 1.80B | 4.60% | 1,610,081 | - |
| 91 | SRPT | Sarepta Therapeutics, Inc. | 1.79B | 3.61% | 4,061,376 | 2.48B |
| 92 | NTLA | Intellia Therapeutics, Inc. | 1.75B | -1.81% | 6,617,783 | 52.86M |
| 93 | PHVS | Pharvaris N.V. | 1.75B | -1.69% | 81,484 | - |
| 94 | CLDX | Celldex Therapeutics, Inc. | 1.74B | 3.52% | 976,042 | 5.79M |
| 95 | AUPH | Aurinia Pharmaceuticals Inc. | 1.73B | 2.26% | 988,348 | 260.11M |
| 96 | IMCR | Immunocore Holdings plc | 1.71B | -0.18% | 365,426 | 356.15M |
| 97 | MNKD | MannKind Corporation | 1.70B | 3.75% | 6,135,980 | 301.74M |
| 98 | EWTX | Edgewise Therapeutics, Inc. | 1.69B | 7.79% | 1,277,508 | - |
| 99 | VRDN | Viridian Therapeutics, Inc. | 1.65B | 5.77% | 638,081 | 305.00K |
| 100 | BHVN | Biohaven Ltd. | 1.59B | 8.54% | 3,502,945 | - |
| 101 | HRMY | Harmony Biosciences Holdings, Inc. | 1.58B | 1.74% | 979,159 | 772.53M |
| 102 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.55B | 5.07% | 3,025,346 | -249.00K |
| 103 | VCEL | Vericel Corporation | 1.53B | 1.31% | 890,322 | 249.12M |
| 104 | GPCR | Structure Therapeutics Inc. | 1.44B | 0.04% | 878,024 | - |
| 105 | DNTH | Dianthus Therapeutics, Inc. | 1.42B | 2.43% | 1,007,757 | 4.85M |
| 106 | ABCL | AbCellera Biologics Inc. | 1.42B | 1.94% | 3,831,203 | 32.88M |
| 107 | JANX | Janux Therapeutics, Inc. | 1.40B | 6.71% | 753,966 | 439.00K |
| 108 | NVAX | Novavax, Inc. | 1.39B | 2.52% | 3,306,611 | 1.08B |
| 109 | RCUS | Arcus Biosciences, Inc. | 1.37B | 3.80% | 635,214 | 262.00M |
| 110 | SNDX | Syndax Pharmaceuticals, Inc. | 1.35B | 4.32% | 2,934,432 | 77.93M |
| 111 | ARDX | Ardelyx, Inc. | 1.34B | -7.05% | 5,478,406 | 386.15M |
| 112 | STOK | Stoke Therapeutics, Inc. | 1.32B | 5.19% | 1,139,304 | 199.89M |
| 113 | XERS | Xeris Biopharma Holdings, Inc. | 1.32B | 4.20% | 1,605,988 | 246.03M |
| 114 | SION | Sionna Therapeutics, Inc. | 1.28B | 5.31% | 216,748 | - |
| 115 | ZYME | Zymeworks Inc. | 1.25B | 2.72% | 530,940 | 122.87M |
| 116 | TRML | Tourmaline Bio, Inc. | 1.23B | 0.04% | 966,651 | - |
| 117 | RAPP | Rapport Therapeutics, Inc. | 1.23B | 6.49% | 1,233,366 | - |
| 118 | CVAC | CureVac N.V. | 1.21B | 0.37% | 352,574 | 599.54M |
| 119 | LENZ | LENZ Therapeutics, Inc. | 1.20B | 5.00% | 322,910 | 5.00M |
| 120 | INVA | Innoviva, Inc. | 1.19B | 1.56% | 525,474 | 370.23M |
| 121 | ELVN | Enliven Therapeutics, Inc. | 1.19B | 7.75% | 529,510 | - |
| 122 | MAZE | Maze Therapeutics, Inc. | 1.18B | 2.47% | 600,280 | 2.50M |
| 123 | ATAI | Atai Life Sciences N.V. | 1.13B | 1.93% | 3,188,755 | 2.31M |
| 124 | YDES | YD Bio Limited | 1.13B | 12.28% | 355,043 | 510.36K |
| 125 | NKTR | Nektar Therapeutics | 1.11B | 5.18% | 1,063,400 | 74.93M |
| 126 | PRAX | Praxis Precision Medicines, Inc. | 1.10B | 5.62% | 521,716 | 7.77M |
| 127 | NUVB | Nuvation Bio Inc. | 1.10B | 6.31% | 4,759,810 | 14.36M |
| 128 | WVE | Wave Life Sciences Ltd. | 1.08B | 2.10% | 2,279,490 | 93.95M |
| 129 | ORIC | ORIC Pharmaceuticals, Inc. | 1.08B | 6.82% | 1,198,120 | - |
| 130 | TRVI | Trevi Therapeutics, Inc. | 1.07B | 3.66% | 1,536,192 | - |
| 131 | PGEN | Precigen, Inc. | 1.05B | 0.72% | 4,385,338 | 4.34M |
| 132 | MDXG | MiMedx Group, Inc. | 1.03B | -0.57% | 572,169 | 363.77M |
| 133 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.01B | -1.02% | 122,268 | - |
| 134 | IMNM | Immunome, Inc. | 1.01B | 14.07% | 5,899,630 | 12.59M |
| 135 | SYRE | Spyre Therapeutics, Inc. | 980.91M | 4.04% | 994,546 | - |
| 136 | SPRY | ARS Pharmaceuticals, Inc. | 968.50M | 2.73% | 2,515,988 | 112.34M |
| 137 | EYPT | EyePoint Pharmaceuticals, Inc. | 958.09M | 5.38% | 833,843 | 51.90M |
| 138 | TNGX | Tango Therapeutics, Inc. | 949.05M | 7.03% | 2,516,249 | 24.30M |
| 139 | IMTX | Immatics N.V. | 936.01M | 9.22% | 571,062 | 152.82M |
| 140 | UPB | Upstream Bio, Inc. | 930.48M | 5.82% | 260,722 | 2.72M |
| 141 | OCS | Oculis Holding AG | 922.68M | 1.00% | 28,185 | 960.67K |
| 142 | PHAR | Pharming Group N.V. | 901.30M | -6.82% | 48,379 | 339.84M |
| 143 | GHRS | GH Research PLC | 895.70M | 7.76% | 1,291,981 | - |
| 144 | RLAY | Relay Therapeutics, Inc. | 891.37M | 18.04% | 4,092,745 | 8.36M |
| 145 | TSHA | Taysha Gene Therapies, Inc. | 886.58M | 6.21% | 4,373,496 | 8.10M |
| 146 | CRMD | CorMedix Inc. | 882.06M | 1.62% | 1,917,976 | 121.48M |
| 147 | SANA | Sana Biotechnology, Inc. | 875.28M | -1.47% | 3,995,504 | - |
| 148 | URGN | UroGen Pharma Ltd. | 848.48M | 6.26% | 1,198,466 | 94.24M |
| 149 | VALN | Valneva SE | 848.21M | -2.41% | 15,280 | 230.57M |
| 150 | RZLT | Rezolute, Inc. | 848.18M | 6.50% | 1,969,694 | - |
| 151 | ZBIO | Zenas BioPharma, Inc. | 846.00M | 7.63% | 109,608 | 15.00M |
| 152 | ABUS | Arbutus Biopharma Corporation | 845.39M | 2.08% | 638,914 | 15.42M |
| 153 | KOD | Kodiak Sciences Inc. | 832.72M | 0.77% | 1,116,553 | - |
| 154 | XNCR | Xencor, Inc. | 825.21M | 12.00% | 1,068,704 | 146.93M |
| 155 | GERN | Geron Corporation | 823.04M | 1.57% | 5,513,068 | 164.45M |
| 156 | IVA | Inventiva S.A. | 821.43M | 0.67% | 27,086 | 14.59M |
| 157 | PHAT | Phathom Pharmaceuticals, Inc. | 820.46M | 1.03% | 825,325 | 114.04M |
| 158 | MNMD | Mind Medicine (MindMed) Inc. | 811.86M | 9.21% | 2,068,623 | - |
| 159 | FTRE | Fortrea Holdings Inc. | 788.14M | -2.69% | 1,070,039 | 2.73B |
| 160 | KURA | Kura Oncology, Inc. | 785.51M | 8.25% | 3,017,784 | 83.28M |
| 161 | MBX | MBX Biosciences, Inc. | 782.70M | 1.04% | 2,145,978 | - |
| 162 | NAGE | Niagen Bioscience, Inc. | 780.02M | 3.72% | 604,708 | 116.30M |
| 163 | SEPN | Septerna, Inc. | 778.01M | 4.18% | 152,454 | 726.00K |
| 164 | IOVA | Iovance Biotherapeutics, Inc. | 763.51M | 4.46% | 10,229,373 | 241.53M |
| 165 | VIR | Vir Biotechnology, Inc. | 762.65M | 5.98% | 2,102,085 | 19.00M |
| 166 | AVXL | Anavex Life Sciences Corp. | 743.84M | 1.88% | 821,599 | - |
| 167 | NBTX | Nanobiotix S.A. | 741.94M | 10.10% | 43,213 | -7.44M |
| 168 | SVRA | Savara Inc. | 741.63M | 1.44% | 1,083,737 | - |
| 169 | PROK | ProKidney Corp. | 732.76M | -4.96% | 1,029,277 | 527.00K |
| 170 | AVBP | ArriVent BioPharma, Inc. | 731.46M | 5.01% | 280,234 | - |
| 171 | MRVI | Maravai LifeSciences Holdings, Inc. | 720.12M | 4.83% | 993,663 | 219.83M |
| 172 | TBPH | Theravance Biopharma, Inc. | 708.58M | 2.03% | 316,094 | 77.21M |
| 173 | DAWN | Day One Biopharmaceuticals, Inc. | 693.46M | 1.35% | 2,138,553 | 187.64M |
| 174 | TYRA | Tyra Biosciences, Inc. | 691.26M | 3.43% | 164,614 | - |
| 175 | NRIX | Nurix Therapeutics, Inc. | 682.69M | 7.20% | 1,474,148 | 88.38M |
| 176 | PRME | Prime Medicine, Inc. | 671.24M | -1.92% | 2,636,136 | 4.96M |
| 177 | TERN | Terns Pharmaceuticals, Inc. | 668.58M | 2.69% | 1,153,862 | - |
| 178 | ANAB | AnaptysBio, Inc. | 660.17M | 6.99% | 593,657 | 123.16M |
| 179 | PVLA | Palvella Therapeutics, Inc. | 659.05M | 3.29% | 202,035 | - |
| 180 | MGTX | MeiraGTx Holdings plc | 658.06M | -0.06% | 330,749 | 37.92M |
| 181 | OLMA | Olema Pharmaceuticals, Inc. | 652.71M | 16.12% | 1,419,751 | - |
| 182 | KROS | Keros Therapeutics, Inc. | 651.88M | 1.58% | 399,627 | 232.84M |
| 183 | GYRE | Gyre Therapeutics, Inc. | 650.32M | -1.78% | 57,290 | 102.19M |
| 184 | CMPX | Compass Therapeutics, Inc. | 641.68M | 7.16% | 1,538,679 | 850.00K |
| 185 | BCAX | Bicara Therapeutics Inc. | 638.93M | 9.44% | 755,117 | - |
| 186 | DNA | Ginkgo Bioworks Holdings, Inc. | 637.39M | 2.22% | 1,059,622 | 230.82M |
| 187 | KALV | KalVista Pharmaceuticals, Inc. | 626.49M | 2.48% | 2,133,943 | 1.43M |
| 188 | GOSS | Gossamer Bio, Inc. | 613.93M | -2.88% | 3,965,304 | 40.24M |
| 189 | ARVN | Arvinas, Inc. | 607.16M | 6.71% | 3,049,095 | 372.80M |
| 190 | ARCT | Arcturus Therapeutics Holdings Inc. | 602.02M | 9.16% | 919,945 | 122.12M |
| 191 | ERAS | Erasca, Inc. | 590.03M | 14.92% | 2,565,337 | - |
| 192 | ORKA | Oruka Therapeutics, Inc. | 569.25M | 1.00% | 423,553 | - |
| 193 | CRVS | Corvus Pharmaceuticals, Inc. | 550.66M | 11.80% | 981,193 | - |
| 194 | ZVRA | Zevra Therapeutics, Inc. | 548.44M | 2.63% | 2,529,379 | 62.02M |
| 195 | VSTM | Verastem, Inc. | 547.14M | 3.25% | 1,179,885 | 2.14M |
| 196 | RIGL | Rigel Pharmaceuticals, Inc. | 513.55M | -0.24% | 700,393 | 267.92M |
| 197 | BCYC | Bicycle Therapeutics plc | 512.87M | -1.92% | 126,418 | 19.28M |
| 198 | IMRX | Immuneering Corporation | 510.97M | 1.00% | 6,008,939 | - |
| 199 | LXRX | Lexicon Pharmaceuticals, Inc. | 508.76M | 4.48% | 3,554,435 | 58.43M |
| 200 | PRTA | Prothena Corporation plc | 506.54M | 0.53% | 722,759 | 10.34M |
| 201 | RGNX | REGENXBIO Inc. | 487.46M | 3.10% | 497,566 | 155.78M |
| 202 | SLDB | Solid Biosciences Inc. | 478.89M | 3.89% | 1,191,727 | - |
| 203 | CTMX | CytomX Therapeutics, Inc. | 478.25M | 2.11% | 9,315,975 | 141.10M |
| 204 | FULC | Fulcrum Therapeutics, Inc. | 478.17M | 4.00% | 613,582 | 80.00M |
| 205 | INBX | Inhibrx Biosciences, Inc. | 473.38M | 2.61% | 173,421 | 1.40M |
| 206 | MNPR | Monopar Therapeutics Inc. | 472.80M | -1.05% | 86,137 | - |
| 207 | OPT | Opthea Limited | 466.57M | - | - | 146.00K |
| 208 | GLUE | Monte Rosa Therapeutics, Inc. | 462.58M | 14.35% | 1,658,264 | 177.99M |
| 209 | OCGN | Ocugen, Inc. | 455.96M | -3.95% | 6,191,348 | 4.75M |
| 210 | XOMA | XOMA Royalty Corporation | 443.38M | 2.97% | 31,795 | 44.95M |
| 211 | RAPT | RAPT Therapeutics, Inc. | 436.27M | 7.89% | 333,477 | - |
| 212 | LRMR | Larimar Therapeutics, Inc. | 436.08M | 4.84% | 3,754,693 | - |
| 213 | ALMS | Alumis Inc. | 421.46M | 1.50% | 862,620 | 20.06M |
| 214 | AUTL | Autolus Therapeutics plc | 415.18M | 4.00% | 3,315,769 | 29.93M |
| 215 | ATXS | Astria Therapeutics, Inc. | 411.97M | 2.10% | 298,218 | - |
| 216 | ADCT | ADC Therapeutics SA | 410.62M | 5.80% | 1,257,152 | 77.25M |
| 217 | ABSI | Absci Corporation | 408.20M | 3.02% | 4,525,672 | 4.14M |
| 218 | PRTC | PureTech Health plc | 405.13M | -1.99% | 616 | 6.39M |
| 219 | ETHZ | ETHZilla Corporation | 402.04M | 7.73% | 7,107,508 | - |
| 220 | IMAB | I-Mab | 400.62M | -1.14% | 288,044 | 569.46K |
| 221 | FDMT | 4D Molecular Therapeutics, Inc. | 391.83M | -0.36% | 875,580 | 33.00K |
| 222 | LCTX | Lineage Cell Therapeutics, Inc. | 390.49M | 10.32% | 2,267,968 | 10.91M |
| 223 | ASMB | Assembly Biosciences, Inc. | 383.87M | -3.13% | 68,044 | 33.25M |
| 224 | AURA | Aura Biosciences, Inc. | 382.66M | 4.76% | 314,247 | - |
| 225 | KRRO | Korro Bio, Inc. | 381.83M | 6.58% | 152,180 | 6.28M |
| 226 | DRUG | Bright Minds Biosciences Inc. | 380.74M | 0.71% | 62,531 | - |
| 227 | DSGN | Design Therapeutics, Inc. | 374.15M | 7.36% | 142,731 | - |
| 228 | ANNX | Annexon, Inc. | 370.32M | 20.79% | 5,479,949 | - |
| 229 | LXEO | Lexeo Therapeutics, Inc. | 365.56M | 4.15% | 706,340 | - |
| 230 | BNTC | Benitec Biopharma Inc. | 359.63M | -2.10% | 25,185 | - |
| 231 | DMAC | DiaMedica Therapeutics Inc. | 358.72M | 1.46% | 128,682 | - |
| 232 | ALT | Altimmune, Inc. | 353.03M | 2.04% | 2,514,891 | 20.00K |
| 233 | CGEM | Cullinan Therapeutics, Inc. | 352.08M | -0.50% | 509,004 | - |
| 234 | RCKT | Rocket Pharmaceuticals, Inc. | 351.77M | 2.19% | 1,798,447 | - |
| 235 | DRTS | Alpha Tau Medical Ltd. | 349.53M | -1.20% | 29,845 | - |
| 236 | LBRX | LB Pharmaceuticals Inc | 346.52M | 2.01% | 131,515 | - |
| 237 | TVRD | Tvardi Therapeutics, Inc. | 340.59M | -1.33% | 45,324 | - |
| 238 | CTNM | Contineum Therapeutics, Inc. | 334.26M | 9.76% | 106,347 | - |
| 239 | ENGN | enGene Holdings Inc. | 332.23M | -0.15% | 39,778 | - |
| 240 | PEPG | PepGen Inc. | 324.73M | -13.78% | 6,066,406 | - |
| 241 | CAPR | Capricor Therapeutics, Inc. | 324.13M | 8.74% | 2,463,908 | 13.39M |
| 242 | REPL | Replimune Group, Inc. | 322.37M | 1.98% | 2,388,506 | - |
| 243 | ALEC | Alector, Inc. | 313.76M | 5.80% | 1,037,178 | 81.13M |
| 244 | MREO | Mereo BioPharma Group plc | 308.65M | 9.60% | 1,829,176 | 500.00K |
| 245 | ALDX | Aldeyra Therapeutics, Inc. | 304.43M | 2.42% | 600,561 | - |
| 246 | CADL | Candel Therapeutics, Inc. | 304.12M | 5.12% | 736,758 | - |
| 247 | SCPH | scPharmaceuticals Inc. | 303.75M | 0.71% | 2,769,521 | 49.97M |
| 248 | OMER | Omeros Corporation | 303.53M | 1.83% | 1,023,958 | - |
| 249 | VNDA | Vanda Pharmaceuticals Inc. | 301.35M | 5.59% | 799,690 | 203.47M |
| 250 | GALT | Galectin Therapeutics Inc. | 291.47M | -1.30% | 154,909 | - |
| 251 | EDIT | Editas Medicine, Inc. | 291.34M | 0.31% | 2,418,345 | 38.90M |
| 252 | TENX | Tenax Therapeutics, Inc. | 290.33M | 6.61% | 182,211 | - |
| 253 | AARD | Aardvark Therapeutics, Inc. | 287.05M | 4.42% | 116,985 | - |
| 254 | TECX | Tectonic Therapeutic, Inc. | 284.42M | 3.33% | 648,211 | - |
| 255 | NMRA | Neumora Therapeutics, Inc. | 281.79M | 2.35% | 270,098 | - |
| 256 | ACIU | AC Immune SA | 281.00M | -2.41% | 141,989 | 36.36M |
| 257 | EPRX | Eupraxia Pharmaceuticals Inc. | 279.00M | -0.35% | 58,485 | - |
| 258 | ABEO | Abeona Therapeutics Inc. | 278.96M | 1.49% | 1,038,259 | 400.00K |
| 259 | ALLO | Allogene Therapeutics, Inc. | 277.35M | 4.17% | 3,298,740 | 22.00K |
| 260 | JBIO | Jade Biosciences, Inc. | 276.67M | 5.21% | 61,561 | - |
| 261 | HUMA | Humacyte, Inc. | 274.79M | 7.45% | 2,168,700 | 818.00K |
| 262 | FHTX | Foghorn Therapeutics Inc. | 274.74M | 3.62% | 129,465 | 24.17M |
| 263 | TNYA | Tenaya Therapeutics, Inc. | 270.54M | 11.41% | 4,452,995 | - |
| 264 | KYTX | Kyverna Therapeutics, Inc. | 263.80M | -3.94% | 398,825 | - |
| 265 | SLN | Silence Therapeutics plc | 261.68M | 10.80% | 63,527 | 27.17M |
| 266 | NGNE | Neurogene Inc. | 254.33M | 2.35% | 119,367 | 925.00K |
| 267 | CLLS | Cellectis S.A. | 252.44M | - | 184,561 | 63.44M |
| 268 | FENC | Fennec Pharmaceuticals Inc. | 251.60M | 3.91% | 104,340 | 33.30M |
| 269 | VYGR | Voyager Therapeutics, Inc. | 250.72M | 10.51% | 979,862 | 42.58M |
| 270 | FBRX | Forte Biosciences, Inc. | 246.81M | -2.88% | 111,410 | - |
| 271 | LYEL | Lyell Immunopharma, Inc. | 246.48M | 0.86% | 54,168 | 60.00K |
| 272 | DBVT | DBV Technologies S.A. | 246.28M | 3.04% | 81,001 | 3.80M |
| 273 | IMMP | Immutep Limited | 244.93M | 2.83% | 97,557 | 3.31M |
| 274 | PBYI | Puma Biotechnology, Inc. | 243.79M | 2.98% | 645,617 | 238.06M |
| 275 | CBIO | Crescent Biopharma, Inc. | 243.00M | 0.16% | 42,907 | - |
| 276 | RNAC | Cartesian Therapeutics, Inc. | 240.78M | -2.11% | 86,424 | 1.03M |
| 277 | SGMT | Sagimet Biosciences Inc. | 238.71M | 2.80% | 286,357 | - |
| 278 | AVIR | Atea Pharmaceuticals, Inc. | 232.52M | 0.69% | 310,580 | - |
| 279 | OABI | OmniAb, Inc. | 231.77M | 3.21% | 379,643 | 23.03M |
| 280 | VOR | Vor Biopharma Inc. | 230.00M | -0.56% | 100,522 | - |
| 281 | TLSA | Tiziana Life Sciences Ltd | 229.61M | -0.48% | 308,332 | - |
| 282 | PRQR | ProQR Therapeutics N.V. | 222.28M | 1.93% | 521,682 | 20.13M |
| 283 | CDXS | Codexis, Inc. | 222.06M | 2.50% | 722,645 | 57.16M |
| 284 | HRTX | Heron Therapeutics, Inc. | 221.81M | -0.82% | 4,108,923 | 149.69M |
| 285 | IVVD | Invivyd, Inc. | 218.35M | -1.75% | 1,770,797 | 46.21M |
| 286 | CABA | Cabaletta Bio, Inc. | 215.86M | 2.16% | 2,117,881 | - |
| 287 | ACRS | Aclaris Therapeutics, Inc. | 215.58M | 6.42% | 820,470 | 16.79M |
| 288 | VTYX | Ventyx Biosciences, Inc. | 212.50M | 10.78% | 947,108 | - |
| 289 | TNXP | Tonix Pharmaceuticals Holding Corp. | 212.22M | 0.88% | 949,337 | 9.83M |
| 290 | TRDA | Entrada Therapeutics, Inc. | 206.21M | 3.94% | 302,181 | 79.48M |
| 291 | SGMO | Sangamo Therapeutics, Inc. | 200.34M | 4.86% | 7,082,920 | 81.71M |
| 292 | CRBU | Caribou Biosciences, Inc. | 198.35M | 10.36% | 1,585,066 | 9.12M |
| 293 | MIST | Milestone Pharmaceuticals Inc. | 195.81M | 1.52% | 939,088 | - |
| 294 | MDWD | MediWound Ltd. | 194.57M | 1.07% | 54,308 | 19.86M |
| 295 | BDTX | Black Diamond Therapeutics, Inc. | 193.58M | 9.32% | 1,075,884 | 70.00M |
| 296 | NTHI | NeOnc Technologies Holdings, Inc. | 193.51M | -2.60% | 67,294 | 59.99K |
| 297 | GNFT | Genfit S.A. | 182.25M | -2.38% | 7,440 | 53.04M |
| 298 | ELTX | Elicio Therapeutics, Inc. | 179.56M | 1.47% | 58,155 | - |
| 299 | APLT | Applied Therapeutics, Inc. | 178.58M | 121.35% | 114,725,027 | 121.00K |
| 300 | GUTS | Fractyl Health, Inc. | 177.14M | 32.67% | 74,896,833 | 17.00K |
| 301 | CHRS | Coherus Oncology, Inc. | 174.34M | 3.45% | 1,584,763 | 272.21M |
| 302 | IPHA | Innate Pharma S.A. | 174.16M | -2.20% | 6,728 | 14.84M |
| 303 | SLS | SELLAS Life Sciences Group, Inc. | 171.63M | 1.24% | 1,456,384 | - |
| 304 | ENTA | Enanta Pharmaceuticals, Inc. | 168.89M | 1.94% | 1,634,488 | 64.81M |
| 305 | MCRB | Seres Therapeutics, Inc. | 165.72M | 0.16% | 54,937 | - |
| 306 | PLX | Protalix BioTherapeutics, Inc. | 164.25M | 0.98% | 382,445 | 61.95M |
| 307 | TARA | Protara Therapeutics, Inc. | 163.97M | -0.93% | 970,193 | - |
| 308 | ELDN | Eledon Pharmaceuticals, Inc. | 161.08M | 8.91% | 3,653,209 | - |
| 309 | VTVT | vTv Therapeutics Inc. | 160.00M | -1.82% | 1,310 | 17.00K |
| 310 | CCCC | C4 Therapeutics, Inc. | 158.71M | 1.83% | 1,757,426 | 34.24M |
| 311 | ACTU | Actuate Therapeutics, Inc. | 157.93M | 1.05% | 37,319 | - |
| 312 | GNLX | Genelux Corporation | 156.83M | -0.71% | 26,715 | 8.00K |
| 313 | ZURA | Zura Bio Limited | 156.69M | 14.76% | 1,368,708 | - |
| 314 | TVGN | Tevogen Bio Holdings Inc. | 156.64M | 1.44% | 307,470 | - |
| 315 | NVCT | Nuvectis Pharma, Inc. | 154.78M | 2.18% | 64,133 | - |
| 316 | ACHV | Achieve Life Sciences, Inc. | 153.83M | 1.35% | 448,061 | - |
| 317 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 148.41M | -0.25% | 73,032 | - |
| 318 | CYBN | Cybin Inc. | 147.66M | - | 573,969 | - |
| 319 | NKTX | Nkarta, Inc. | 144.89M | 2.00% | 487,439 | - |
| 320 | SAVA | Cassava Sciences, Inc. | 144.44M | -3.55% | 2,722,119 | - |
| 321 | CLYM | Climb Bio, Inc. | 144.34M | 1.43% | 351,096 | - |
| 322 | STTK | Shattuck Labs, Inc. | 143.99M | -0.44% | 275,920 | 3.00M |
| 323 | AVTX | Avalo Therapeutics, Inc. | 142.05M | -6.49% | 304,000 | 441.00K |
| 324 | GLSI | Greenwich LifeSciences, Inc. | 141.75M | -0.19% | 105,373 | - |
| 325 | CRDF | Cardiff Oncology, Inc. | 137.04M | 0.98% | 605,904 | 545.00K |
| 326 | KALA | KALA BIO, Inc. | 133.75M | 4.56% | 395,572 | - |
| 327 | SEER | Seer, Inc. | 133.39M | 3.18% | 80,679 | 16.29M |
| 328 | PYXS | Pyxis Oncology, Inc. | 132.72M | 3.88% | 354,585 | 2.82M |
| 329 | INO | Inovio Pharmaceuticals, Inc. | 131.79M | 2.06% | 617,187 | 182.34K |
| 330 | MOLN | Molecular Partners AG | 130.94M | 5.94% | 2,749 | 856.30K |
| 331 | OBIO | Orchestra BioMed Holdings, Inc. | 130.57M | -1.23% | 206,365 | 2.94M |
| 332 | EXOZ | eXoZymes, Inc. | 129.83M | 6.38% | 9,963 | -700.00 |
| 333 | ONCY | Oncolytics Biotech Inc. | 129.47M | 3.20% | 699,795 | - |
| 334 | CGEN | Compugen Ltd. | 129.08M | 1.45% | 88,448 | 22.14M |
| 335 | SKYE | Skye Bioscience, Inc. | 127.36M | 14.17% | 772,214 | - |
| 336 | AGEN | Agenus Inc. | 125.86M | 1.28% | 494,643 | 101.71M |
| 337 | BMEA | Biomea Fusion, Inc. | 124.97M | 2.44% | 670,137 | - |
| 338 | HURA | TuHURA Biosciences, Inc. | 123.12M | 0.41% | 115,884 | - |
| 339 | OVID | Ovid Therapeutics Inc. | 123.02M | 22.70% | 6,528,965 | 6.65M |
| 340 | CGTX | Cognition Therapeutics, Inc. | 117.34M | 5.56% | 1,565,512 | - |
| 341 | FBIO | Fortress Biotech, Inc. | 116.34M | 4.27% | 1,215,083 | 59.30M |
| 342 | IKT | Inhibikase Therapeutics, Inc. | 115.50M | - | 88,634 | 1.00 |
| 343 | FATE | Fate Therapeutics, Inc. | 115.33M | 3.01% | 1,330,798 | 8.47M |
| 344 | IRD | Opus Genetics, Inc. | 114.74M | 5.81% | 549,984 | 15.42M |
| 345 | ACOG | Alpha Cognition Inc. | 114.42M | -8.29% | 120,012 | 4.59M |
| 346 | TIL | Instil Bio, Inc. | 114.29M | 1.68% | 128,897 | - |
| 347 | ANIX | Anixa Biosciences, Inc. | 111.92M | 0.74% | 77,640 | - |
| 348 | ZNTL | Zentalis Pharmaceuticals, Inc. | 111.81M | 4.03% | 898,816 | 26.87M |
| 349 | ATOS | Atossa Therapeutics, Inc. | 110.89M | 5.12% | 465,197 | - |
| 350 | MGNX | MacroGenics, Inc. | 109.35M | 4.85% | 515,434 | 165.50M |
| 351 | ARMP | Armata Pharmaceuticals, Inc. | 109.05M | 1.01% | 6,843 | 6.87M |
| 352 | VTGN | Vistagen Therapeutics, Inc. | 108.30M | 4.75% | 287,762 | 646.00K |
| 353 | ANRO | Alto Neuroscience, Inc. | 106.95M | 3.95% | 62,078 | - |
| 354 | SPRO | Spero Therapeutics, Inc. | 106.36M | -2.58% | 397,251 | 48.58M |
| 355 | TCRX | TScan Therapeutics, Inc. | 104.98M | 3.93% | 201,559 | 6.96M |
| 356 | KLRS | Kalaris Therapeutics, Inc. | 104.92M | 17.61% | 251,447 | - |
| 357 | NAUT | Nautilus Biotechnology, Inc. | 104.68M | 0.57% | 495,748 | - |
| 358 | IOBT | IO Biotech, Inc. | 104.09M | - | 580,624 | - |
| 359 | PTHS | Pelthos Therapeutics Inc. | 102.82M | 1.68% | 14,859 | - |
| 360 | ALXO | ALX Oncology Holdings Inc. | 100.14M | 4.47% | 699,383 | - |
| 361 | SRZN | Surrozen, Inc. | 99.07M | -3.10% | 5,732 | 12.62M |
| 362 | ORMP | Oramed Pharmaceuticals Inc. | 98.82M | 0.42% | 31,816 | 2.00M |
| 363 | ANEB | Anebulo Pharmaceuticals, Inc. | 98.60M | -1.64% | 36,760 | - |
| 364 | ATRA | Atara Biotherapeutics, Inc. | 96.50M | -0.65% | 36,831 | 188.67M |
| 365 | HOWL | Werewolf Therapeutics, Inc. | 94.66M | 2.48% | 1,099,889 | 1.14M |
| 366 | ADVM | Adverum Biotechnologies, Inc. | 94.64M | 4.64% | 456,633 | 1.00M |
| 367 | PLRX | Pliant Therapeutics, Inc. | 93.31M | 5.56% | 369,103 | - |
| 368 | IMUX | Immunic, Inc. | 92.64M | 4.54% | 1,788,050 | - |
| 369 | ADAG | Adagene Inc. | 92.38M | -2.97% | 10,669 | 103.20K |
| 370 | COYA | Coya Therapeutics, Inc. | 91.82M | 3.39% | 39,292 | 423.45K |
| 371 | WHWK | Whitehawk Therapeutics, Inc. | 91.43M | 2.12% | 90,587 | 21.60M |
| 372 | EQ | Equillium, Inc. | 89.25M | 7.14% | 742,975 | 16.55M |
| 373 | IFRX | InflaRx N.V. | 88.07M | 0.78% | 195,708 | 191.22K |
| 374 | CNTB | Connect Biopharma Holdings Limited | 88.04M | -6.51% | 92,458 | 1.97M |
| 375 | NTRB | Nutriband Inc. | 87.24M | 1.81% | 16,733 | 2.58M |
| 376 | CSBR | Champions Oncology, Inc. | 86.87M | -1.41% | 2,409 | 56.88M |
| 377 | QNCX | Quince Therapeutics, Inc. | 86.48M | -1.23% | 390,140 | - |
| 378 | IMA | ImageneBio, Inc. | 86.21M | -0.90% | 4,073 | 4.30M |
| 379 | ABOS | Acumen Pharmaceuticals, Inc. | 86.01M | -4.05% | 1,743,558 | - |
| 380 | MGX | Metagenomi, Inc. | 85.95M | -0.43% | 859,471 | 33.77M |
| 381 | PRLD | Prelude Therapeutics Incorporated | 84.90M | 22.95% | 734,955 | 7.00M |
| 382 | VANI | Vivani Medical, Inc. | 84.72M | - | 61,514 | - |
| 383 | COEP | Coeptis Therapeutics Holdings, Inc. | 84.36M | 5.04% | 35,617 | 263.56K |
| 384 | VXRT | Vaxart, Inc. | 83.89M | 2.01% | - | 80.72M |
| 385 | ENTX | Entera Bio Ltd. | 83.11M | 1.68% | 67,345 | 166.00K |
| 386 | HYFT | MindWalk Holdings Corp. | 83.08M | 1.69% | 417,720 | 18.21M |
| 387 | ATYR | aTyr Pharma, Inc. | 82.36M | -5.91% | 16,705,773 | 235.00K |
| 388 | XBIT | XBiotech Inc. | 82.32M | 0.37% | 37,952 | - |
| 389 | OKYO | OKYO Pharma Limited | 81.99M | -4.50% | 56,158 | - |
| 390 | CNTX | Context Therapeutics Inc. | 81.63M | 0.76% | 102,067 | - |
| 391 | SLGL | Sol-Gel Technologies Ltd. | 80.76M | 2.57% | 7,318 | 23.93M |
| 392 | PMVP | PMV Pharmaceuticals, Inc. | 78.43M | 5.71% | 182,519 | - |
| 393 | XFOR | X4 Pharmaceuticals, Inc. | 77.68M | 2.37% | 410,087 | 32.77M |
| 394 | CRVO | CervoMed Inc. | 76.61M | 5.88% | 82,146 | 7.78M |
| 395 | STRO | Sutro Biopharma, Inc. | 75.16M | 2.34% | 406,523 | 104.47M |
| 396 | RPTX | Repare Therapeutics Inc. | 72.60M | 1.20% | 41,839 | 250.00K |
| 397 | NSRX | Nasus Pharma Ltd. | 72.48M | -0.62% | 23,911 | - |
| 398 | ARTV | Artiva Biotherapeutics, Inc. | 72.30M | -1.66% | 193,792 | 251.00K |
| 399 | ABVC | ABVC BioPharma, Inc. | 72.08M | 1.28% | 114,319 | 391.24K |
| 400 | CVM | CEL-SCI Corporation | 71.54M | 5.17% | 53,026 | - |
| 401 | UNCY | Unicycive Therapeutics, Inc. | 71.00M | 7.49% | 297,572 | - |
| 402 | BYSI | BeyondSpring Inc. | 70.98M | 4.76% | 9,559 | 1.88M |
| 403 | CBUS | Cibus, Inc. | 70.51M | - | 121,067 | 4.85M |
| 404 | NRXP | NRx Pharmaceuticals, Inc. | 70.12M | 1.37% | 218,966 | - |
| 405 | ACET | Adicet Bio, Inc. | 69.93M | 0.14% | 236,423 | - |
| 406 | JSPR | Jasper Therapeutics, Inc. | 68.97M | 6.01% | 734,859 | - |
| 407 | IMMX | Immix Biopharma, Inc. | 67.94M | 1.96% | 183,344 | - |
| 408 | ATHE | Alterity Therapeutics Limited | 67.61M | -2.66% | 19,184 | 3.57M |
| 409 | OSTX | OS Therapies Incorporated | 64.87M | -2.84% | 404,373 | - |
| 410 | GANX | Gain Therapeutics, Inc. | 64.35M | 3.47% | 459,292 | - |
| 411 | ANL | Adlai Nortye Ltd. | 63.47M | -3.37% | 10,090 | 1.94M |
| 412 | INKT | MiNK Therapeutics, Inc. | 63.14M | 2.57% | 58,668 | - |
| 413 | MNOV | MediciNova, Inc. | 62.29M | 1.61% | 7,329 | 134.60K |
| 414 | PSTV | Plus Therapeutics, Inc. | 61.26M | 9.61% | 114,693,486 | 5.32M |
| 415 | QNTM | Quantum BioPharma Ltd. | 60.70M | -4.39% | 126,960 | - |
| 416 | ALGS | Aligos Therapeutics, Inc. | 60.22M | 4.59% | 55,890 | 3.17M |
| 417 | CAMP | Camp4 Therapeutics Corporation | 60.08M | -0.67% | 175,599 | 3.01M |
| 418 | RLMD | Relmada Therapeutics, Inc. | 60.08M | 9.04% | 350,811 | - |
| 419 | CELU | Celularity Inc. | 60.06M | 10.29% | 911,008 | 44.59M |
| 420 | DTIL | Precision BioSciences, Inc. | 59.64M | 2.23% | 56,246 | 1.26M |
| 421 | GNTA | Genenta Science S.p.A. | 57.80M | 1.12% | 6,255 | - |
| 422 | KPTI | Karyopharm Therapeutics Inc. | 56.80M | -1.65% | 48,518 | 137.27M |
| 423 | JUNS | Jupiter Neurosciences, Inc. | 55.38M | 13.57% | 486,767 | - |
| 424 | VERU | Veru Inc. | 54.65M | 3.90% | 210,807 | 16.89M |
| 425 | ICCC | ImmuCell Corporation | 54.55M | -0.17% | 7,033 | 28.27M |
| 426 | CUE | Cue Biopharma, Inc. | 54.55M | 2.85% | 109,310 | 8.29M |
| 427 | HYPD | Hyperion DeFi, Inc. | 54.50M | 13.12% | 798,399 | 44.44K |
| 428 | MAIA | MAIA Biotechnology, Inc. | 53.45M | 3.18% | 198,463 | - |
| 429 | INMB | INmune Bio, Inc. | 53.44M | -0.99% | 439,364 | 50.00K |
| 430 | BTAI | BioXcel Therapeutics, Inc. | 53.05M | -4.26% | 1,306,763 | 868.00K |
| 431 | ACRV | Acrivon Therapeutics, Inc. | 52.22M | 7.79% | 305,885 | - |
| 432 | PYPD | PolyPid Ltd. | 52.21M | -1.19% | 73,641 | - |
| 433 | SER | Serina Therapeutics, Inc. | 50.95M | -0.20% | 10,295 | 130.00K |
| 434 | ATNM | Actinium Pharmaceuticals, Inc. | 50.23M | 1.26% | 100,961 | 81.00K |
| 435 | FGEN | FibroGen, Inc. | 49.78M | 0.49% | 15,456 | 7.35M |
| 436 | BRNS | Barinthus Biotherapeutics plc | 49.68M | 0.83% | 37,960 | 14.97M |
| 437 | LTRN | Lantern Pharma Inc. | 48.11M | 2.89% | 108,167 | - |
| 438 | PDSB | PDS Biotechnology Corporation | 47.97M | -0.97% | 445,502 | - |
| 439 | TELO | Telomir Pharmaceuticals, Inc. | 47.03M | -0.71% | 629,784 | - |
| 440 | RADX | Radiopharm Theranostics Limited | 44.88M | - | 31,568 | 8.20M |
| 441 | ESLA | Estrella Immunopharma, Inc. | 44.48M | 4.35% | 111,086 | - |
| 442 | IPSC | Century Therapeutics, Inc. | 43.98M | 4.39% | 534,455 | 114.13M |
| 443 | RNXT | RenovoRx, Inc. | 43.24M | 0.85% | 215,956 | 662.00K |
| 444 | OTLK | Outlook Therapeutics, Inc. | 43.09M | -0.39% | 912,073 | 1.51M |
| 445 | CALC | CalciMedica, Inc. | 43.03M | 2.33% | 15,997 | - |
| 446 | GRCE | Grace Therapeutics, Inc. | 42.73M | 0.32% | 29,097 | - |
| 447 | LVTX | LAVA Therapeutics N.V. | 41.83M | 0.13% | 147,105 | 4.99M |
| 448 | TPST | Tempest Therapeutics, Inc. | 41.65M | 0.75% | 19,368 | - |
| 449 | XLO | Xilio Therapeutics, Inc. | 41.25M | 4.83% | 487,548 | 15.00M |
| 450 | GBIO | Generation Bio Co. | 40.41M | 4.90% | 89,444 | 21.23M |
| 451 | CLGN | CollPlant Biotechnologies Ltd. | 39.93M | 9.19% | 41,773 | 2.40M |
| 452 | DYAI | Dyadic International, Inc. | 39.81M | -5.98% | 76,461 | 4.14M |
| 453 | APLM | Apollomics, Inc. | 39.56M | 0.02% | - | 198.00K |
| 454 | VRCA | Verrica Pharmaceuticals Inc. | 39.48M | 2.20% | 42,891 | 14.70M |
| 455 | BCAB | BioAtla, Inc. | 39.29M | 6.22% | 429,232 | 11.00M |
| 456 | ADAP | Adaptimmune Therapeutics plc | 38.96M | 15.75% | 87,538,879 | 65.09M |
| 457 | ANVS | Annovis Bio, Inc. | 38.39M | -7.51% | 770,321 | - |
| 458 | PLUR | Pluri Inc. | 37.93M | 2.47% | 19,774 | 1.34M |
| 459 | MRSN | Mersana Therapeutics, Inc. | 37.78M | 5.58% | 39,764 | 34.77M |
| 460 | LIMN | Liminatus Pharma, Inc. | 37.72M | - | 807,928 | - |
| 461 | IGC | IGC Pharma, Inc. | 36.57M | 1.77% | 304,857 | 1.33M |
| 462 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 36.39M | - | 603,937 | 1.00M |
| 463 | SNTI | Senti Biosciences, Inc. | 36.36M | -0.71% | 74,063 | - |
| 464 | MURA | Mural Oncology plc | 36.21M | - | 268,183 | - |
| 465 | RANI | Rani Therapeutics Holdings, Inc. | 34.50M | 0.17% | 205,711 | 1.20M |
| 466 | ANTX | AN2 Therapeutics, Inc. | 34.16M | 0.81% | 21,521 | - |
| 467 | OKUR | OnKure Therapeutics, Inc. | 33.96M | -1.18% | 24,735 | - |
| 468 | ITRM | Iterum Therapeutics plc | 32.15M | -3.11% | 467,566 | - |
| 469 | AKTX | Akari Therapeutics, Plc | 31.64M | -13.38% | 207,041 | - |
| 470 | NRSN | NeuroSense Therapeutics Ltd. | 31.05M | 5.08% | 237,259 | - |
| 471 | RENB | Lunai Bioworks Inc. | 30.04M | -7.47% | 3,821,326 | - |
| 472 | NRXS | NeurAxis, Inc. | 29.52M | 8.73% | 101,520 | 3.22M |
| 473 | CVKD | Cadrenal Therapeutics, Inc. | 28.72M | -1.20% | 18,197 | - |
| 474 | KLTO | Klotho Neurosciences, Inc. | 27.91M | -4.65% | 1,008,671 | - |
| 475 | DARE | Daré Bioscience, Inc. | 27.55M | 0.48% | 117,479 | -17.70K |
| 476 | RNTX | Rein Therapeutics Inc. | 27.50M | -1.26% | 150,298 | - |
| 477 | KZR | Kezar Life Sciences, Inc. | 26.73M | -2.67% | 47,929 | - |
| 478 | EVAX | Evaxion A/S | 25.52M | -10.82% | 1,837,782 | 3.18M |
| 479 | BOLD | Boundless Bio, Inc. | 25.52M | 0.88% | 106,948 | - |
| 480 | PASG | Passage Bio, Inc. | 25.43M | 4.17% | 81,576 | - |
| 481 | ENLV | Enlivex Therapeutics Ltd. | 24.57M | - | 124,339 | - |
| 482 | MBRX | Moleculin Biotech, Inc. | 24.35M | 11.87% | 7,472,005 | - |
| 483 | XCUR | Exicure, Inc. | 24.07M | -2.81% | 7,332 | 500.00K |
| 484 | FBLG | FibroBiologics, Inc. | 24.03M | 6.28% | 758,763 | - |
| 485 | MTVA | MetaVia Inc. | 23.47M | -2.99% | 114,750 | - |
| 486 | PPCB | Propanc Biopharma, Inc. | 23.23M | 0.55% | 92,079 | - |
| 487 | NEUP | Neuphoria Therapeutics Inc. | 23.14M | -1.12% | 50,367 | 15.66M |
| 488 | LIXT | Lixte Biotechnology Holdings, Inc. | 23.08M | -3.62% | 373,385 | - |
| 489 | QTTB | Q32 Bio Inc. | 23.05M | 0.53% | 129,753 | - |
| 490 | RLYB | Rallybio Corporation | 22.98M | -2.67% | 762,608 | 761.00K |
| 491 | GDTC | CytoMed Therapeutics Limited | 22.96M | 4.06% | 25,045 | 368.84K |
| 492 | HOTH | Hoth Therapeutics, Inc. | 22.87M | -4.70% | 612,095 | - |
| 493 | NNVC | NanoViricides, Inc. | 22.82M | 1.43% | 42,869 | - |
| 494 | KAPA | Kairos Pharma, Ltd. | 22.82M | -3.51% | 959,645 | - |
| 495 | LSTA | Lisata Therapeutics, Inc. | 21.63M | 4.44% | 21,742 | 1.07M |
| 496 | CING | Cingulate Inc. | 21.36M | 0.53% | 92,667 | - |
| 497 | PMN | ProMIS Neurosciences, Inc. | 21.18M | 2.46% | 542,001 | - |
| 498 | CLSD | Clearside Biomedical, Inc. | 21.15M | 8.31% | 99,001 | 4.17M |
| 499 | CRIS | Curis, Inc. | 21.12M | 1.22% | 82,509 | 11.41M |
| 500 | SABS | SAB Biotherapeutics, Inc. | 20.93M | -4.29% | 199,017 | 114.70K |
| 501 | LEXX | Lexaria Bioscience Corp. | 20.54M | -31.37% | 12,131,701 | 615.92K |
| 502 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 20.45M | - | 5,584,966 | - |
| 503 | SYBX | Synlogic, Inc. | 20.36M | 4.82% | 17,672 | 8.00K |
| 504 | CASI | CASI Pharmaceuticals, Inc. | 20.30M | -13.30% | 1,746,550 | 31.56M |
| 505 | ALLR | Allarity Therapeutics, Inc. | 20.19M | 2.60% | 399,623 | - |
| 506 | CTXR | Citius Pharmaceuticals, Inc. | 19.56M | - | 235,904 | - |
| 507 | BCTX | BriaCell Therapeutics Corp. | 19.42M | 3.08% | 105,103 | - |
| 508 | ASBP | Aspire Biopharma Holdings, Inc. | 17.79M | -4.95% | 671,408 | - |
| 509 | CLRB | Cellectar Biosciences, Inc. | 17.62M | -4.00% | 83,100 | - |
| 510 | EDSA | Edesa Biotech, Inc. | 17.52M | 2.05% | 2,235 | - |
| 511 | ABP | Abpro Holdings, Inc. | 17.47M | 2.16% | 2,173,566 | 183.00K |
| 512 | LGVN | Longeveron Inc. | 16.83M | 0.67% | 412,343 | 2.07M |
| 513 | ICU | SeaStar Medical Holding Corporation | 16.81M | -1.00% | 3,738,621 | 766.00K |
| 514 | THAR | Tharimmune, Inc. | 16.63M | 3.78% | 233,032 | - |
| 515 | GOVX | GeoVax Labs, Inc. | 16.38M | 0.84% | 268,043 | 6.14M |
| 516 | COCP | Cocrystal Pharma, Inc. | 16.30M | - | 153,993 | - |
| 517 | PULM | Pulmatrix, Inc. | 16.18M | 2.72% | 8,561 | 369.00K |
| 518 | BLRX | BioLineRx Ltd. | 16.00M | 1.32% | 26,879 | 17.25M |
| 519 | IBIO | iBio, Inc. | 15.94M | 1.79% | 178,387 | 400.00K |
| 520 | NXTC | NextCure, Inc. | 15.25M | -1.38% | 9,465 | - |
| 521 | ATHA | Athira Pharma, Inc. | 15.22M | 1.31% | 16,375 | - |
| 522 | BCDA | BioCardia, Inc. | 15.06M | 0.71% | 294,410 | 3.00K |
| 523 | NERV | Minerva Neurosciences, Inc. | 14.83M | -3.00% | 8,740 | - |
| 524 | LPCN | Lipocine Inc. | 14.79M | 1.87% | 23,844 | 4.21M |
| 525 | LPTX | Leap Therapeutics, Inc. | 14.50M | 1.13% | 998,616 | - |
| 526 | CANF | Can-Fite BioPharma Ltd. | 14.09M | 2.46% | 74,973 | 560.00K |
| 527 | BIVI | BioVie Inc. | 14.01M | 3.33% | 151,014 | - |
| 528 | PHGE | BiomX Inc. | 13.89M | 0.58% | 242,543 | - |
| 529 | CMMB | Chemomab Therapeutics Ltd. | 13.66M | 5.60% | 288,485 | - |
| 530 | IMRN | Immuron Limited | 13.34M | 0.26% | 30,613 | 4.78M |
| 531 | APM | Aptorum Group Limited | 13.22M | 3.35% | 62,306 | - |
| 532 | TRAW | Traws Pharma, Inc. | 13.07M | -1.60% | 30,350 | 2.90M |
| 533 | IMNN | Imunon, Inc. | 13.06M | -0.19% | 32,940 | - |
| 534 | PLRZ | Polyrizon Ltd. | 12.79M | 1.89% | 206,665 | - |
| 535 | PHIO | Phio Pharmaceuticals Corp. | 12.77M | 1.36% | 92,026 | - |
| 536 | NBY | NovaBay Pharmaceuticals, Inc. | 12.75M | 2.34% | 196,978 | 9.78M |
| 537 | OSRH | OSR Holdings, Inc. | 12.52M | -3.32% | 12,398,511 | 104.74K |
| 538 | MRKR | Marker Therapeutics, Inc. | 12.29M | 7.76% | 411,627 | 5.39M |
| 539 | CARM | Carisma Therapeutics, Inc. | 12.11M | 7.73% | 716,898 | 10.77M |
| 540 | INTS | Intensity Therapeutics, Inc. | 11.90M | -2.18% | 1,064,553 | - |
| 541 | MBIO | Mustang Bio, Inc. | 11.51M | -0.63% | 44,594 | - |
| 542 | BRTX | BioRestorative Therapies, Inc. | 11.41M | -0.69% | 170,733 | 605.20K |
| 543 | ARTL | Artelo Biosciences, Inc. | 11.13M | -0.90% | 14,975 | - |
| 544 | SNSE | Sensei Biotherapeutics, Inc. | 11.10M | 0.34% | 500 | - |
| 545 | XTLB | XTL Biopharmaceuticals Ltd. | 11.03M | -1.68% | 3,384 | 451.00K |
| 546 | PCSA | Processa Pharmaceuticals, Inc. | 10.72M | 10.36% | 1,793,786 | - |
| 547 | LYRA | Lyra Therapeutics, Inc. | 10.64M | 1.73% | 7,273 | 770.00K |
| 548 | MTNB | Matinas BioPharma Holdings, Inc. | 10.55M | 1.06% | 26,412 | - |
| 549 | DWTX | Dogwood Therapeutics, Inc. | 10.55M | 8.02% | 68,924 | - |
| 550 | BOLT | Bolt Biotherapeutics, Inc. | 10.40M | -1.99% | 44,421 | 4.17M |
| 551 | INAB | IN8bio, Inc. | 10.40M | 9.57% | 268,574 | - |
| 552 | EVGN | Evogene Ltd. | 10.08M | 2.70% | 32,353 | 9.44M |
| 553 | AEON | AEON Biopharma, Inc. | 9.80M | 8.13% | 159,046 | - |
| 554 | EPIX | ESSA Pharma Inc. | 9.51M | 0.40% | 1,134,145 | - |
| 555 | KPRX | Kiora Pharmaceuticals, Inc. | 8.96M | 1.48% | 21,548 | 20.00K |
| 556 | HCWB | HCW Biologics Inc. | 8.80M | 0.25% | 32,997 | 832.84K |
| 557 | ERNA | Ernexa Therapeutics Inc. | 8.74M | 1.79% | 33,626 | 488.00K |
| 558 | QLGN | Qualigen Therapeutics, Inc. | 8.58M | -8.33% | 576,733 | - |
| 559 | CELZ | Creative Medical Technology Holdings, Inc. | 8.53M | 1.54% | 18,690 | 6.00K |
| 560 | APRE | Aprea Therapeutics, Inc. | 8.50M | -0.35% | 38,142 | 841.01K |
| 561 | RNAZ | TransCode Therapeutics, Inc. | 8.48M | 2.52% | 27,346 | - |
| 562 | VYNE | VYNE Therapeutics Inc. | 8.45M | 5.00% | 1,464,320 | 476.00K |
| 563 | VIVS | VivoSim Labs, Inc. | 8.35M | -6.96% | 73,347 | 142.00K |
| 564 | PTIX | Protagenic Therapeutics, Inc. | 8.22M | 1.18% | 41,247 | - |
| 565 | KZIA | Kazia Therapeutics Limited | 8.19M | 0.01% | 4,548 | 1.55M |
| 566 | PALI | Palisade Bio, Inc. | 8.19M | 16.20% | 1,236,677 | - |
| 567 | IBO | Impact BioMedical Inc. | 8.02M | 1.53% | 143,852 | 7.00K |
| 568 | ADXN | Addex Therapeutics Ltd | 8.01M | -1.11% | 4,962 | 278.51K |
| 569 | CYCN | Cyclerion Therapeutics, Inc. | 7.75M | -11.36% | 190,712 | 2.17M |
| 570 | GNPX | Genprex, Inc. | 7.67M | -3.51% | 3,263,887 | - |
| 571 | GLMD | Galmed Pharmaceuticals Ltd. | 7.67M | 1.45% | 40,126 | - |
| 572 | NCNA | NuCana plc | 7.65M | 0.75% | 148,104 | - |
| 573 | ALZN | Alzamend Neuro, Inc. | 7.57M | 2.12% | 130,717 | - |
| 574 | ENTO | Entero Therapeutics, Inc. | 7.55M | 0.85% | 92,974 | - |
| 575 | ADIL | Adial Pharmaceuticals, Inc. | 7.51M | 2.81% | 604,146 | - |
| 576 | SILO | Silo Pharma, Inc. | 7.29M | 3.91% | 753,798 | 72.10K |
| 577 | CDIO | Cardio Diagnostics Holdings, Inc. | 7.18M | 0.25% | 9,559 | 19.51K |
| 578 | NLSP | NLS Pharmaceutics AG | 6.92M | 6.31% | 524,180 | - |
| 579 | ENSC | Ensysce Biosciences, Inc. | 6.65M | -0.88% | 93,725 | 7.41M |
| 580 | PMCB | PharmaCyte Biotech, Inc. | 6.59M | -0.10% | 29,206 | - |
| 581 | CERO | CERo Therapeutics Holdings, Inc. | 6.50M | 0.19% | 296,521 | - |
| 582 | CLDI | Calidi Biotherapeutics, Inc. | 6.32M | 8.28% | 131,495 | - |
| 583 | ACXP | Acurx Pharmaceuticals, Inc. | 6.18M | 0.75% | 15,716 | - |
| 584 | GLTO | Galecto, Inc. | 5.84M | -0.90% | 218,805 | - |
| 585 | CMND | Clearmind Medicine Inc. | 5.74M | -0.94% | 146,256 | - |
| 586 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 5.58M | -2.16% | 25,028 | 984.49K |
| 587 | TTNP | Titan Pharmaceuticals, Inc. | 5.52M | 2.98% | 8,547 | - |
| 588 | TCRT | Alaunos Therapeutics, Inc. | 5.50M | -0.20% | 15,668 | 6.00K |
| 589 | KTTA | Pasithea Therapeutics Corp. | 5.41M | 2.47% | 70,756 | - |
| 590 | OGEN | Oragenics, Inc. | 5.24M | -0.78% | 74,853 | - |
| 591 | ONCO | Onconetix, Inc. | 5.24M | 6.27% | 1,381,643 | 1.33M |
| 592 | SNGX | Soligenix, Inc. | 5.14M | -25.93% | 6,820,278 | 2.34K |
| 593 | CNSP | CNS Pharmaceuticals, Inc. | 5.11M | 2.89% | 10,695 | - |
| 594 | APVO | Aptevo Therapeutics Inc. | 4.93M | -6.25% | 2,092,691 | - |
| 595 | GRI | GRI Bio, Inc. | 4.90M | 1.04% | 179,337 | - |
| 596 | XBIO | Xenetic Biosciences, Inc. | 4.78M | -4.32% | 6,878 | 2.45M |
| 597 | PPBT | Purple Biotech Ltd | 4.75M | 3.81% | 380,651 | - |
| 598 | JAGX | Jaguar Health, Inc. | 4.68M | 4.88% | 72,442 | 11.81M |
| 599 | MLEC | Moolec Science SA | 4.57M | -0.01% | 25,018 | 7.83M |
| 600 | SPRB | Spruce Biosciences, Inc. | 4.36M | - | 824 | 1.30M |
| 601 | QNRX | Quoin Pharmaceuticals, Ltd. | 4.28M | -1.73% | 23,046 | - |
| 602 | ADTX | Aditxt, Inc. | 4.20M | -1.08% | 400,931 | 12.05K |
| 603 | XRTX | XORTX Therapeutics Inc. | 4.04M | -6.98% | 57,397 | - |
| 604 | BDRX | Biodexa Pharmaceuticals Plc | 3.93M | -3.93% | 12,079 | 104.90K |
| 605 | INDP | Indaptus Therapeutics, Inc. | 3.86M | 6.40% | 14,793,674 | - |
| 606 | TOVX | Theriva Biologics, Inc. | 3.81M | 1.90% | 106,476 | - |
| 607 | ELAB | PMGC Holdings Inc. | 3.66M | 7.36% | 33,867 | -605.53K |
| 608 | DRMA | Dermata Therapeutics, Inc. | 3.54M | 11.61% | 81,802 | - |
| 609 | REVB | Revelation Biosciences, Inc. | 3.35M | 2.14% | 221,821 | - |
| 610 | GTBP | GT Biopharma, Inc. | 2.73M | 0.92% | 1,992,778 | - |
| 611 | VRAX | Virax Biolabs Group Limited | 2.66M | -2.26% | 162,651 | 6.33K |
| 612 | AZTR | Azitra, Inc. | 2.47M | -2.48% | 177,982 | 7.50K |
| 613 | SPRC | SciSparc Ltd. | 2.29M | -29.72% | 1,475,009 | 1.31M |
| 614 | CDT | CDT Equity Inc. | 2.12M | -1.39% | 463,803 | - |
| 615 | SLXN | Silexion Therapeutics Corp | 2.06M | -2.39% | 65,489 | - |
| 616 | SCNI | Scinai Immunotherapeutics Ltd. | 2.00M | -1.49% | 41,274 | 1.15M |
| 617 | ENVB | Enveric Biosciences, Inc. | 1.97M | -0.62% | 242,145 | - |
| 618 | SLRX | Salarius Pharmaceuticals, Inc. | 1.94M | -3.54% | 128,930 | - |
| 619 | PBM | Psyence Biomedical Ltd. | 1.81M | 1.30% | 110,006 | - |